Gide has advised Erytech Pharma, a company listed on Euronext Paris, on its initial public offering on the Nasdaq Global Select Market, through a reserved capital increase to American and European specialist investors for a total aggregate amount of USD144 million, after full exercise of the over-allotment option.
Apellis Pharmaceuticals, a portfolio company of early-stage venture capital fund Epidarex Capital, has completed its initial public offering (IPO).
GCA Altium has acted as financial and nominated adviser on the IPO of Footasylum plc, a UK-based fashion retailer focusing on the branded footwear and apparel markets.
Osborne Clarke advises Berenberg and Grant Thornton on GBP163m Alpha Financial Markets Consulting AIM IPO
International legal practice Osborne Clarke has advised Joh Berenberg, Gossler & Co KG, London branch, and Grant Thornton UK on the successful GBP163 million AIM market IPO of Alpha Financial Consulting Group plc, a provider of specialist consultancy services to the asset and wealth management industry.
McCarthy Denning has advised new Curzon Energy on the admission of its shares to the Standard List to trade on the main market of the London Stock Exchange (LSE). The company raised gross proceeds of GBP2.3 million by a placing and subscription at the time of admission.
Nasdaq has successfully completed 90 Special Purpose Acquisition Companies (SPACs) initial public offerings (IPOs) raising USD15.3 billion in total.
The Luxembourg Stock Exchange (LuxSE) has listed the first ever Reserved Alternative Investment Fund (RAIF). The new RAIF was brought to market by Finexis and has been listed on the Euro MTF market.
Independent investment bank Zeus Capital has supported two major IPOs in consecutive days on the London Stock Exchange’s Alternative Investment Market (AIM).
Mid Europa Partners (Mid Europa), a private equity investor in Central and South Eastern Europe, has listed its portfolio company, Waberer’s International (Waberer’s) through an initial public offering (IPO) on the Budapest Stock Exchange.
Jaisal Pastakia, Investment Manager at Heartwood Investment Management comments on the sate of the healthcare and biotech sectors…